Go Pro

genedrive (GDR) Competitors

genedrive logo
GBX 1.05 -0.15 (-12.58%)
As of 05:50 AM Eastern

GDR vs. ABDX, YGEN, VRCI, AGL, and GENI

Should you buy genedrive stock or one of its competitors? MarketBeat compares genedrive with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with genedrive include Abingdon Health (ABDX), Yourgene Health (YGEN), Verici Dx (VRCI), ANGLE (AGL), and GENinCode (GENI). These companies are all part of the "diagnostics & research" industry.

How does genedrive compare to Abingdon Health?

genedrive (LON:GDR) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

0.1% of genedrive shares are owned by institutional investors. Comparatively, 3.7% of Abingdon Health shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 8.0% of Abingdon Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, genedrive had 2 more articles in the media than Abingdon Health. MarketBeat recorded 2 mentions for genedrive and 0 mentions for Abingdon Health. genedrive's average media sentiment score of 0.48 beat Abingdon Health's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company Overall Sentiment
genedrive Neutral
Abingdon Health Neutral

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
genedrive£929K18.13-£21.22M-£0.79N/A
Abingdon Health£9.57M2.57-£796.37K-£0.81N/A

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
genedrive-500.75% -1,044.57% -74.09%
Abingdon Health -33.88%-55.91%-17.93%

genedrive has a beta of 0.989, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

Summary

genedrive beats Abingdon Health on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to Yourgene Health?

genedrive (LON:GDR) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

0.1% of genedrive shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 29.0% of genedrive shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
genedrive£929K18.13-£21.22M-£0.79N/A
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
genedrive-500.75% -1,044.57% -74.09%
Yourgene Health -27.55%-27.06%-6.71%

genedrive has a beta of 0.989, meaning that its share price is 1% less volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

In the previous week, genedrive had 2 more articles in the media than Yourgene Health. MarketBeat recorded 2 mentions for genedrive and 0 mentions for Yourgene Health. genedrive's average media sentiment score of 0.48 beat Yourgene Health's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company Overall Sentiment
genedrive Neutral
Yourgene Health Neutral

Summary

Yourgene Health beats genedrive on 8 of the 12 factors compared between the two stocks.

How does genedrive compare to Verici Dx?

Verici Dx (LON:VRCI) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Verici Dx has a beta of 1.256, indicating that its stock price is 26% more volatile than the broader market. Comparatively, genedrive has a beta of 0.989, indicating that its stock price is 1% less volatile than the broader market.

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verici Dx£3.66M2.53-£6.56M-£0.90N/A
genedrive£929K18.13-£21.22M-£0.79N/A

In the previous week, genedrive had 1 more articles in the media than Verici Dx. MarketBeat recorded 2 mentions for genedrive and 1 mentions for Verici Dx. genedrive's average media sentiment score of 0.48 beat Verici Dx's score of -1.31 indicating that genedrive is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Verici Dx
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Negative
genedrive
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

7.9% of Verici Dx shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 1.3% of Verici Dx shares are held by insiders. Comparatively, 29.0% of genedrive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Verici Dx has a net margin of -193.05% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -138.93% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
Verici Dx-193.05% -138.93% -26.14%
genedrive -500.75%-1,044.57%-74.09%

Summary

Verici Dx beats genedrive on 8 of the 13 factors compared between the two stocks.

How does genedrive compare to ANGLE?

genedrive (LON:GDR) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
genedrive£929K18.13-£21.22M-£0.79N/A
ANGLE£2.62M2.89-£21.76M-£4.80N/A

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
genedrive-500.75% -1,044.57% -74.09%
ANGLE -1,444.04%-191.36%-29.89%

In the previous week, genedrive had 2 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for genedrive and 0 mentions for ANGLE. ANGLE's average media sentiment score of 1.28 beat genedrive's score of 0.48 indicating that ANGLE is being referred to more favorably in the news media.

Company Overall Sentiment
genedrive Neutral
ANGLE Positive

0.1% of genedrive shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 2.7% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

genedrive has a beta of 0.989, indicating that its share price is 1% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market.

Summary

genedrive beats ANGLE on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to GENinCode?

GENinCode (LON:GENI) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

11.4% of GENinCode shares are owned by institutional investors. Comparatively, 0.1% of genedrive shares are owned by institutional investors. 8.4% of GENinCode shares are owned by insiders. Comparatively, 29.0% of genedrive shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GENinCode£3.08M1.88-£6.10M-£2.08N/A
genedrive£929K18.13-£21.22M-£0.79N/A

GENinCode has a net margin of -185.47% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -409.40% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
GENinCode-185.47% -409.40% -63.99%
genedrive -500.75%-1,044.57%-74.09%

In the previous week, genedrive had 2 more articles in the media than GENinCode. MarketBeat recorded 2 mentions for genedrive and 0 mentions for GENinCode. genedrive's average media sentiment score of 0.48 beat GENinCode's score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company Overall Sentiment
GENinCode Neutral
genedrive Neutral

GENinCode has a beta of 0.593, suggesting that its share price is 41% less volatile than the broader market. Comparatively, genedrive has a beta of 0.989, suggesting that its share price is 1% less volatile than the broader market.

Summary

GENinCode beats genedrive on 7 of the 13 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GDR vs. The Competition

MetricgenedriveDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£16.84M£693.09M£6.96B£2.77B
Dividend Yield1.57%3.36%2.68%6.12%
P/E Ratio-1.3373.0427.20368.14
Price / Sales18.13581.72578.1384,676.43
Price / Cash2.0011.4249.2527.89
Price / Book0.373.1310.747.50
Net Income-£21.22M£334.07B£3.59B£5.89B
7 Day Performance-22.30%-1.19%-1.92%-0.04%
1 Month Performance-19.31%0.75%2.23%-1.39%
1 Year Performance-26.33%6.74%23.82%61.97%

genedrive Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDR
genedrive
N/AGBX 1.05
-12.6%
N/A-13.7%£16.84M£929KN/A43
ABDX
Abingdon Health
N/AGBX 10.28
+0.3%
N/A+35.7%£25.74M£9.57MN/A84
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67MN/A253
VRCI
Verici Dx
N/AGBX 0.37
-2.7%
N/A-75.2%£11.20M£3.66MN/A19
AGL
ANGLE
N/AGBX 2.35
-11.3%
N/A-53.0%£7.58M£2.62MN/A650

Related Companies and Tools


This page (LON:GDR) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners